arginine vasopressin has been researched along with rb 150 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balavoine, F; Bodineau, L; Fassot, C; Frugière, A; Inguimbert, N; Llorens-Cortes, C; Marc, Y; Roques, B | 1 |
| Azizi, M; Balavoine, F; Bergerot, D; De Mota, N; Llorens-Cortes, C; Patouret, R; Roques, BP | 1 |
| Balavoine, F; Flahault, A; Hmazzou, R; Llorens-Cortes, C; Marc, Y | 1 |
1 trial(s) available for arginine vasopressin and rb 150
| Article | Year |
|---|---|
Randomised, double-blind, placebo-controlled, dose-escalating phase I study of QGC001, a centrally acting aminopeptidase a inhibitor prodrug.
Topics: Adolescent; Adult; Antihypertensive Agents; Arginine Vasopressin; Disulfides; Dose-Response Relationship, Drug; Double-Blind Method; Glutamyl Aminopeptidase; Heart Rate; Humans; Male; Prodrugs; Protease Inhibitors; Renin-Angiotensin System; Sulfonic Acids; Young Adult | 2014 |
2 other study(ies) available for arginine vasopressin and rb 150
| Article | Year |
|---|---|
Orally active aminopeptidase A inhibitors reduce blood pressure: a new strategy for treating hypertension.
Topics: Administration, Oral; Animals; Arginine Vasopressin; Blood Pressure; Disease Models, Animal; Disulfides; Diuresis; Drinking; Enzyme Inhibitors; Glutamyl Aminopeptidase; Hypertension; Male; Rats; Rats, Inbred Dahl; Rats, Inbred WKY; Sulfonic Acids | 2008 |
Central antihypertensive effects of chronic treatment with RB150: an orally active aminopeptidase A inhibitor in deoxycorticosterone acetate-salt rats.
Topics: Administration, Oral; Animals; Antihypertensive Agents; Arginine Vasopressin; Blood Pressure; Brain; Desoxycorticosterone Acetate; Disulfides; Enzyme Inhibitors; Glutamyl Aminopeptidase; Hypertension; Male; Natriuresis; Rats; Sulfonic Acids | 2018 |